JBJacques Belghiti

Jacques Belghiti

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jacques Belghiti has a total of 29 co-authors. Here are the top co-authors by number of shared publications:

  • Alain Sauvanet

    Department of Hepato‐Bilio‐Pancreatic Surgery and Liver Transplantation Beaujon Hospital, Assistance Publique‐Hôpitaux de Paris, Clichy, University Paris Cité Paris France

    5 shared publications
  • François Durand

    Hepatology & Liver Intensive Care, Beaujon Hospital, Clichy, France; University Paris Cité, Paris, France

    4 shared publications
  • Daniele Sommacale

    From the Departments of *Hepato-Pancreato-Biliary Surgery and Transplantation and †Hepatology and Transplantation, Hospital Beaujon, University Paris VII, Clichy, France

    2 shared publications
  • Kurumboor Prakash

    From the Departments of *Hepato-Pancreato-Biliary Surgery and Transplantation and †Hepatology and Transplantation, Hospital Beaujon, University Paris VII, Clichy, France

    2 shared publications
  • Olivier Farges

    From the Departments of *Hepato-Pancreato-Biliary Surgery and Transplantation and †Hepatology and Transplantation, Hospital Beaujon, University Paris VII, Clichy, France

    2 shared publications
  • Reza Kianmanesh

    From the Departments of *Hepato-Pancreato-Biliary Surgery and Transplantation and †Hepatology and Transplantation, Hospital Beaujon, University Paris VII, Clichy, France

    2 shared publications

Latest Publications

  • Auxiliary liver transplantation for acute liver failure

    by J. Belghiti, D. Sommacale, F. Dondéro, F. Zinzindohoué, A. Sauvanet, F. Durand

    The main causes of acute liver failure (ALF) leading to consideration of patients for liver transplantation (LT) are viral hepatitis including B infection and drug‐ or toxin‐induced hepatic injury including paracetamol overdose. In the majority of cases, patients who were previously healthy can recover without liver parenchymal sequelae. Severe forms progress to multisystem failure including cerebral oedema, which can cause death within a few hours or a few days. In this situation, LT is the only effective treatment that can substitute metabolic and excretory function of the liver. LT is indicated when severe encephalopathy (confusion or coma) is associated with an important decrease of the coagulation factors (factor V < 20%) [ 1 x 1 Bernuau, J., Rueff, B., and Benhamou, J.P. Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis. 1986; 6: 97–106 Crossref | PubMed | Scopus (469) | Google Scholar See all References 1 ]. Orthotopic liver transplantation (OLT) is an established treatment for ALF with 1‐year patient survival rates of approximately 60–70% [ 2 x 2 Bismuth, H., Samuel, D., Castaing, D., Williams, R., and Pereira, S.P. Liver transplantation in Europe for patients with acute liver failure. Semin Liver Dis. 1996; 16: 415–425 Crossref | PubMed | Scopus (126) | Google Scholar See all References 2 ]. Nevertheless, a significant minority of patients with ALF who fulfil transplant criteria would have had complete morphological and functional recovery of their liver if they had not undergone OLT [ 3 x 3 Wolf, H.K. and Michalopoulos, G.K. Hepatocyte regeneration in acute fulminant and nonfulminant hepatitis: a study of proliferating cell nuclear antigen expression. Hepatology. 1992; 15: 707–713 Crossref | PubMed | Scopus (112) | Google Scholar See all References 3 ]. These considerations have led to the concept of auxiliary liver transplantation, which does not exclude the potential for spontaneous regeneration of the native liver and eventual withdrawal of immunosuppressive drugs [ 4 x 4 Moritz, M.J., Jarrell, B.E., Armenti, V. et al. Heterotopic liver transplantation for fulminant hepatic failure – a bridge to recovery. Transplantation. 1990; 50: 524–526 Crossref | PubMed | Google Scholar See all References , 5 x 5 Gubernatis, G., Pichlmayr, R., Kemnitz, J. et al. Auxiliary partial orthotopic liver transplantation (APOLT) for fulminant hepatic failure: first successful case report. World J Surg. 1991; 15: 660–666 Crossref | PubMed | Scopus (147) | Google Scholar See all References , 6 x 6 Moritz, M.J., Jarrell, B.E., Munoz, S.J., and Maddrey, W.C. Regeneration of the native liver after heterotopic liver transplantation for fulminant hepatic failure. Transplantation. 1993; 55: 952–954 PubMed | Google Scholar See all References , 7 x 7 Boudjema, K., Jaeck, D., Siméoni, U. et al. Temporary auxiliary liver transplantation for subacute liver failure in a child. Lancet. 1993; 342: 778–779 Abstract | PubMed | Scopus (46) | Google Scholar See all References ]. Auxiliary liver transplantation consists of implanting a healthy liver graft placed either heterotopically or orthotopically while leaving all or part of the native liver. Early experience with heterotopic placement of the graft below the native liver has been disappointing with a high rate of technical failure, probably due to inadequate portal perfusion of the graft and insufficient drainage of hepatic blood flow in an area of low pressure (Figure 1 Figure 1 ) [ 4 x 4 Moritz, M.J., Jarrell, B.E., Armenti, V. et al. Heterotopic liver transplantation for fulminant hepatic failure – a bridge to recovery. Transplantation. 1990; 50: 524–526 Crossref | PubMed | Google Scholar See all References , 8 x 8 Terpstra, O.T., Reuvers, C.B., and Schalm, S.W. Auxiliary heterotopic liver transplantation. Transplantation. 1988; 45: 1003–1007 Crossref | PubMed | Scopus (55) | Google Scholar See all References , 9 x 9 Metselaar, H.J., Hesselink, E.J., De Rave, S. et al. Recovery of failing liver after auxiliary heterotopic transplantation. Lancet. 1990; 335: 1156–1157 Abstract | PubMed | Scopus (45) | Google Scholar See all References 9 ]. The favourable outcome reported in a European series using auxiliary partial orthotopic liver transplantation (APOLT), the greater experience as well as the lessons from split liver and from living related donors have revived interest in this approach [ 10 x 10 Chenard‐Neu, M.P., Boudjema, K., and Bernuau, J. Auxiliary liver transplantation: regeneration of the native liver and outcome in 30 patients with fulminant hepatic failure. A multicenter European study. Hepatology. 1996; 23: 1119–1127 PubMed | Google Scholar See all References , 11 x 11 Van Hoek, B., De Boer, J., Boudjema, K. et al. Auxiliary versus orthotopic liver transplantation for acute liver failure. J Hepatol. 1999; 30: 699–705 Abstract | Full Text | Full Text PDF | PubMed | Scopus (119) | Google Scholar See all References , 12 x 12 Durand, F., Belghiti, J., Handra‐Luca, A. et al. Auxiliary liver transplantation for fulminant hepatitis B: results from a series of six patients with special emphasis on regeneration and recurrence of hepatitis B. Liver Transpl. 2002; 8: 701–707 Crossref | PubMed | Scopus (21) | Google Scholar See all References ]. The aim of this paper is to summarize our current selection of patients, technical procedure and the postoperative management, focusing on the withdrawal of immunosuppression.


  • Top Cited Papers

    Resection Prior to Liver Transplantation for Hepatocellular Carcinoma

    by Jacques Belghiti, Alexandre Cortes, Eddie K. Abdalla, Jean-Marc Régimbeau, Kurumboor Prakash, François Durand, Daniele Sommacale, Federica Dondero, Mickael Lesurtel, Alain Sauvanet, et al.

    To evaluate the feasibility and postoperative course of liver transplantation (LT) in cirrhotic patients who underwent liver resection prior to LT for HCC. Although LT provides longer survival than liver resection for treatment of small HCCs, donor shortage and long LT wait time may argue against LT. The feasibility and survival following LT after hepatic resection have not been previously examined. Between 1991 and 2001, among 107 patients who underwent LT for HCC, 88 met Mazzafero's criteria upon pathologic analysis of the explant. Of these, 70 underwent primary liver transplantation (PLT) and 18 liver resection prior to secondary liver transplantation (SLT) for recurrence (n = 11), deterioration of liver function (n = 4), or high risk for recurrence (n = 3). Perioperative and postoperative factors and long-term survival were compared. Comparison of PLT and SLT groups at the time of LT revealed similar median age (53 vs. 55 years), sex, and etiology of liver disease (alcohol/viral B/C/other). In the SLT group, the mean time between liver resection and listing for LT was 20 months (range 1–84 months). Overall time on LT waiting list of the two groups was similar (3 vs. 5 months). Pathologic analysis after LT revealed similar tumor size (2.2 vs. 2.3 cm) and number (1.6 vs. 1.7). Perioperative and postoperative courses were not different in terms of operative time (551 vs. 530 minutes), blood loss (1191 vs. 1282 mL), transfusion (3 vs. 2 units), ICU (9 vs. 10 days) or hospital stay (32 vs. 31 days), morbidity (51% vs. 56%) or 30-day mortality (5.7% vs. 5.6%). During a median follow-up of 32 months (3 to 158 months), 3 patients recurred after PLT and one after SLT. After transplantation, 3- and 5-year overall survivals were not different between groups (82 vs. 82% and 59 vs. 61%). In selected patients, liver resection prior to transplantation does not increase the morbidity or impair long-term survival following LT. Therefore, liver resection prior to transplantation can be integrated in the treatment strategy for HCC.


  • Surgical techniques used in adult living donor liver transplantation

    by Jacques Belghiti, Reza Kianmanesh

    Key points: 1. The main goal of hepatectomy for adult living donor liver transplantation (ALDLT) is to provide a graft with sufficient volume and adequate vascular inflow and outflow. 2. Although the risk is increased in the donor, right grafts, which provide maximum liver volume, are used by a majority of transplant teams. 3. Although right grafts are easily positioned in the donor, facilitating the right hepatic vein anastomosis, the venous drainage is not always complete because the anterior sector is drained through the middle hepatic vein. 4. The harvesting of the middle hepatic vein, which allows the optimal venous drainage for the recipient, is debated with the fear of adverse effects for the donor. 5. The back-table procedure is essential for vascular reconstruction of the hepatic veins and for portal and arterial reconstruction in case of dual vessels. 6. There is a tendency to perform duct-to-duct biliary anastomosis. 7. The use of left grafts, which are an anatomical entity with single inflow and outflow orfices, is limited by the small volume of the grafts. 8. In order to overcome the small-for-size syndrome, some promising technical procedures (partial porto-systemic shunt and splenic artery ligation) are under evaluation.


  • Pancréatite aiguë clinique après chimio-embolisation sélective d'un carcinome hépatocellulaire

    by M.H Roullet, A Denys, A Sauvanet, O Farges, V Vilgrain, J Belghiti


  • Open Access

    Management of Spontaneous Rupture of Liver Tumours

    by P. Marini, V. Vilgrain, J. Belghiti

    Spontaneous ruptures of a liver tumour are often considered as a potentially life-threatening situation. The aim of the present study was to evaluate both clinical features and treatment in a subgroup of patients with ruptured liver tumours. From 1995 to 2000, 20 patients were referred to our centre for spontaneous rupture of a liver tumour associated with haemoperitoneum. Hepatocellular carcinoma (HCC) was present in 13 patients (11 men and 2 women) aged from 48 to 72 years (mean 62) and adenoma in 7 women aged from 23 to 52 years (mean 35). Although all patients experienced sudden abdominal pain and anaemia, shock at admission was present in 4 (20%) patients including 3 with HCC. In patients with HCC, severe liver insufficiency (Child-Pugh C) was present in 5 cases including the 3 shocked patients. No treatment was undertaken in 2 patients, transarterial embolization was performed in 9 cases and 5 patients underwent delayed resection. In hospital, mortality was observed in 3 (23%) patients, all of them had severe liver insufficiency. Long-term survival was observed in patients with good liver function who underwent resection. In patients with adenoma, shock at admission was observed in only 1 patient under anticoagulation treatment. Emergency resection was performed in 3 cases. A decrease of the tumour size was observed in patients who underwent delayed resection resulting in a lower rate of peri-operative transfusion. In conclusion, this study confirms that the majority of patients with ruptured liver tumours had no evidence of haemodynamic instability and therefore should be initially managed conservatively. In patients with single ruptured HCC associated with good liver function, long-term survival can be observed after liver resection. Delayed resection facilitated the operative procedure in patients with ruptured adenoma.


    • 11 April 2002
      • Vol. 49  (43) , 41-6

    Resection of hepatocellular carcinoma: a European experience on 328 cases.

    by J Belghiti, J M Regimbeau, F Durand, A R Kianmanesh, F Dondero, B Terris, A Sauvanet, O Farges, F Degos

    Surgical liver resection has been demonstrated in Asian countries to be the best therapeutic option in patients with hepatocellular carcinoma. Because the value of this treatment is still debated in Western countries, the aim of this paper was to report a European experience of resection for hepatocellular carcinoma. From 1990 to 1999, 239 men and 61 women aged from 15 to 77 years old underwent 328 resections including major resection in 138 (42%) cases. Normal liver was present in 53 patients (17%) and chronic liver disease was present in 247 including 152 (50%) with cirrhosis. In-hospital mortality was 6.4% and was significantly influenced by the presence of chronic liver disease (1.7% vs. 7.4%). Mortality after resection in alcoholic patients (14%), in patients with hepatitis C (9%) was significantly higher than in patients chronic hepatitis B (1%) (P < 0.05). The overall survival rates were 81%, 57%, 37%, and 13% at 1, 3, 5 and 10 years. Five-year survival rate was significantly higher (P < 0.05) in patients with normal liver as compared to chronic liver disease (50% vs. 34%). In patients with chronic liver disease parameters, which significantly influenced survival rate, were vascular invasion, tumor differentiation and the extent of resection. In this European study with varied profile of etiologies associated with hepatocellular carcinoma we showed that a five-year survival rate of 40% can be expected after resection and that chronic liver disease is a major factor influencing short and long-term prognosis.


  • Book Review Surgery Edited by John D. Corson and Robin C.N. Williamson. 1664 pp., illustrated. St. Louis, Mosby, 2001. $175. 0-7234-3069-1

    by Jacques Belghiti

    To publish a one-volume textbook of surgery at the beginning of the new millennium is a challenging task, especially in view of the fragmentation of surgery into subspecialties. As growth of the surgical specialties continues, the role and future of general surgeons will require redefinition. Surgery is the result of a remarkable collaboration of more than 250 authors worldwide.

  • Open Access

    Feasibility and limits of caval-flow preservation during liver transplantation

    by Jacques Belghiti, Giuseppe M. Ettorre, Francois Durand, Daniele Sommacale, Alain Sauvanet, John T. Jerius, Olivier Farges

    As promoters of orthotopic liver transplantation (OLT) with preservation of caval flow, we reviewed our 8-year experience to assess the feasibility and limits of this technique. Preservation of caval flow during OLT, which improves intraoperative hemodynamic stability, was not considered feasible in a significant proportion of transplant recipients. When transient clamping of caval flow is required, causes and consequences of this clamping during all phases of the procedure were not reported. Between 1991 and 1998, a total of 275 OLTs using a whole graft were performed in 259 patients with a policy consisting of a systematic attempt to preserve inferior vena cava (IVC) and caval flow. Preservation of IVC flow was possible in all cases, and no procedure was converted to the conventional technique. Caval flow was maintained throughout the procedure in 246 procedures (90%). Temporary IVC cross-clamping was required in 24 cases during hepatectomy because of difficult dissection and in 5 cases after graft reperfusion because of outflow obstruction; none required the use of a venovenous shunt. IVC cross-clamping during hepatectomy was required more frequently in cases of a large liver, with a mean duration of 11 ± 4 minutes, but without significant influence on early postoperative risk, including one graft failure (4%) and one postoperative death (4%). Conversely, IVC cross-clamping after reperfusion, with a mean duration of 23 ± 5 minutes, was associated with four graft failures (80%) and four deaths (80%). We conclude that IVC preservation is feasible in almost all candidates, allowing the use of split livers from cadaveric or living donors independently from their underlying disease. Although preservation of caval flow was possible in the large majority of cases, transient IVC cross-clamping during hepatectomy was well tolerated in contrast to caval clamping after graft reperfusion. Therefore, if necessary, we recommend transient IVC cross-clamping to perform a large cavocaval anastomosis.